YECO OTC
EV Biologics, Inc.
1W: +0.0%
1M: -75.0%
3M: -50.0%
YTD: -99.9%
1Y: -99.9%
3Y: -100.0%
5Y: -99.9%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$126K
+0.0% ▲
Capital Expenditures
$0
-100.0% ▼
Free Cash Flow
-$126K
+0.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$127K
+0.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$99K | -$388K | -$21M | -$1M | -$299K |
| Depreciation & Amort. | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $197K | $1M | $214K | -$2M | $172K |
| Other Non-Cash Items | $0 | $119K | -$76K | $0 | $0 |
| Operating Cash Flow | $98K | $698K | -$21M | -$3M | -$126K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | -$19M | $0 | -$39K | $0 |
| Acquisitions (Net) | $0 | $0 | $7M | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | -$2M | $13M | $11M | $0 |
| Investing Cash Flow | $0 | -$22M | $20M | $11M | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | -$272 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $5K | $22M | $2M | -$8M | $0 |
| Financing Cash Flow | $5K | $22M | $2M | -$8M | -$272 |
| Net Change in Cash | $102K | $498K | -$265K | -$208K | -$127K |
| Cash End of Period | $102K | $600K | $335K | $127K | $16 |
| Free Cash Flow | $98K | -$19M | -$21M | -$3M | -$126K |